Jefferson Wright Tilley, North Caldwell US
Jefferson Wright Tilley, North Caldwell, NJ US
Patent application number | Description | Published |
---|---|---|
20080255198 | BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATOR - The present invention relates to compounds of formula (I) | 10-16-2008 |
20080287421 | 3,3-SPIROINDOLINONE DERIVATIVES - There are provided compounds of the general formulas | 11-20-2008 |
20090005383 | THYROID HORMONE ANALOGS - Provided herein are compounds of the formula (I): | 01-01-2009 |
20090082310 | PRODRUGS OF THYROID HORMONE ANALOGS - Provided herein are compounds of the formula (I): | 03-26-2009 |
20090156635 | BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATORS - The present invention relates to compounds of formula (I) | 06-18-2009 |
20090253684 | LEUKOTRIENE B4 INHIBITORS - Provided herein are compounds of the formula (I): | 10-08-2009 |
20090264434 | PYRIDAZINONE GLUCOKINASE ACTIVATORS - Provided herein are compounds of the formula (I): | 10-22-2009 |
20090264445 | PYRROLIDINONE GLUCOKINASE ACTIVATORS - Provided herein are compounds of the formula (I): | 10-22-2009 |
20090270505 | 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES - This invention relates to novel 4-dimethylaminobutyric acid derivatives of the formula | 10-29-2009 |
20090286812 | GPR119 Receptor Agonists - Provided herein are compounds of the formula (I): | 11-19-2009 |
20100069307 | NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS - Provided herein are neuropeptide-2 receptor agonists of the formula (I): | 03-18-2010 |
20100137223 | NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS AND USES THEREOF - Provided herein are neuropeptide-2 receptor agonists of the formula (I): | 06-03-2010 |
20100179093 | Neoropeptide-2-Receptor (Y-2R) Agonists - Provided herein are neuropeptide-2 receptor agonists of the formula (I): | 07-15-2010 |
20100240678 | LEUKOTRIENE B4 INHIBITORS - Provided herein are compounds of the formula (I): | 09-23-2010 |
20110021570 | PYRIDONE GLUCOKINASE ACTIVATORS - Provided herein are compounds of the formula (I): | 01-27-2011 |
20110144105 | AZAINDOLE GLUCOKINASE ACTIVATORS - Provided herein are compounds of the formula (I): | 06-16-2011 |
20110172147 | NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS - Provided herein are neuropeptide-2 receptor agonists of the formula (I): | 07-14-2011 |
20120101037 | GLUCOSE-DEPENDENT INSULINOTROPIC PEPTIDE ANALOGS - The present invention provides compounds which are analogs of glucose-dependent insulinotropic polypeptide (GIP) and pharmaceutically acceptable salts of such compounds. These compounds have activity as agonists of GIP receptor. | 04-26-2012 |
20120289554 | 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES - This invention relates to novel 4-dimethylaminobutyric acid derivatives of the formula | 11-15-2012 |
20130131113 | PYRIDONE GLUCOKINASE ACTIVATORS - Provided herein are compounds of the formula (I): | 05-23-2013 |
20130150407 | PIPERIDINYL NAPHTHYLACETIC ACIDS - The invention is concerned with the compounds of formula (I): | 06-13-2013 |
20130225588 | SUBSTITUTED NAPHTHYLACETIC ACIDS - The invention is concerned with the compounds of formula (I): | 08-29-2013 |